Diferencia entre revisiones de «Acute angle-closure glaucoma»

(Major update: pilocarpine ineffective until IOP <40-50, sickle cell contraindication, simultaneous multidrug approach, prophylactic fellow eye iridotomy, medication timing, references with PMIDs)
(Strip excess bold)
 
Línea 4: Línea 4:
*Sudden increase in [[intraocular pressure]] (IOP) due to obstruction of aqueous humor outflow through the trabecular meshwork
*Sudden increase in [[intraocular pressure]] (IOP) due to obstruction of aqueous humor outflow through the trabecular meshwork
*'''Ophthalmologic emergency''' — permanent vision loss can occur within hours
*'''Ophthalmologic emergency''' — permanent vision loss can occur within hours
*Normal IOP: 10-21 mmHg; in acute attack: typically '''40-80 mmHg'''
*Normal IOP: 10-21 mmHg; in acute attack: typically 40-80 mmHg
*Pathophysiology:
*Pathophysiology:
**Pupillary dilation → peripheral iris contacts trabecular meshwork → blocks aqueous outflow
**Pupillary dilation → peripheral iris contacts trabecular meshwork → blocks aqueous outflow
**Increased posterior chamber pressure → iris bows forward ('''iris bombe''') → further obstruction
**Increased posterior chamber pressure → iris bows forward (iris bombe) → further obstruction
*Risk factors:
*Risk factors:
**Hyperopia (farsightedness — smaller anterior chamber)
**Hyperopia (farsightedness — smaller anterior chamber)
**'''Asian''' and Inuit descent (anatomically shallow anterior chambers)
**Asian and Inuit descent (anatomically shallow anterior chambers)
**Female sex, age >40
**Female sex, age >40
**Family history
**Family history
*'''Precipitants''': dim lighting, medications causing mydriasis (anticholinergics, sympathomimetics, topiramate), emotional stress
*Precipitants: dim lighting, medications causing mydriasis (anticholinergics, sympathomimetics, topiramate), emotional stress


==Clinical Features==
==Clinical Features==
[[File:Ciliary flush acute angle closure.jpg|thumb|Ciliary/circumcorneal flush and hazy cornea characteristic of acute angle closure glaucoma.]]
[[File:Ciliary flush acute angle closure.jpg|thumb|Ciliary/circumcorneal flush and hazy cornea characteristic of acute angle closure glaucoma.]]
[[File:Acute angle closure pupil.jpg|thumb|Right eye with mid-sized, fixed pupil and ciliary flush.]]
[[File:Acute angle closure pupil.jpg|thumb|Right eye with mid-sized, fixed pupil and ciliary flush.]]
*'''Sudden onset, severe unilateral eye pain'''
*Sudden onset, severe unilateral eye pain
*'''Blurred vision''' with '''"halos" around lights''' (corneal edema)
*Blurred vision with "halos" around lights (corneal edema)
*'''Frontal or supraorbital headache'''
*Frontal or supraorbital headache
*'''Nausea and vomiting''' (may be prominent → misdiagnosed as GI illness)
*Nausea and vomiting (may be prominent → misdiagnosed as GI illness)
*'''Fixed, mid-dilated pupil''' (oval or irregular)
*Fixed, mid-dilated pupil (oval or irregular)
*'''Hazy, edematous cornea''' (steamy appearance)
*Hazy, edematous cornea (steamy appearance)
*'''Ciliary flush''' (conjunctival injection most prominent at limbus)
*Ciliary flush (conjunctival injection most prominent at limbus)
*'''Rock-hard globe''' on palpation (elevated IOP)
*Rock-hard globe on palpation (elevated IOP)
*'''Decreased visual acuity'''
*Decreased visual acuity


==Differential Diagnosis==
==Differential Diagnosis==
Línea 39: Línea 39:


==Evaluation==
==Evaluation==
*'''IOP measurement''' (Tono-Pen or Goldmann):
*IOP measurement (Tono-Pen or Goldmann):
**'''IOP >21 mmHg''' (typically >40 mmHg in acute attack)
**IOP >21 mmHg (typically >40 mmHg in acute attack)
*'''Slit lamp exam''':
*Slit lamp exam:
**Shallow anterior chamber
**Shallow anterior chamber
**Corneal edema
**Corneal edema
Línea 48: Línea 48:


===Diagnostic Criteria: 3 Signs + 2 Symptoms===
===Diagnostic Criteria: 3 Signs + 2 Symptoms===
*At least '''3 signs''': IOP >21 mmHg, conjunctival injection, corneal epithelial edema, mid-dilated nonreactive pupil, shallow anterior chamber
*At least 3 signs: IOP >21 mmHg, conjunctival injection, corneal epithelial edema, mid-dilated nonreactive pupil, shallow anterior chamber
*At least '''2 symptoms''': ocular pain, nausea/vomiting, history of intermittent blurring with halos
*At least 2 symptoms: ocular pain, nausea/vomiting, history of intermittent blurring with halos


==Management==
==Management==
*'''Goal: rapidly lower IOP to prepare for definitive laser iridotomy'''<ref>Primary Angle Closure Preferred Practice Pattern. American Academy of Ophthalmology. 2016.</ref>
*Goal: rapidly lower IOP to prepare for definitive laser iridotomy<ref>Primary Angle Closure Preferred Practice Pattern. American Academy of Ophthalmology. 2016.</ref>
*'''Emergent ophthalmology consult'''
*Emergent ophthalmology consult
*'''Recheck IOP at least hourly'''
*Recheck IOP at least hourly
*'''Position''': elevate head of bed, keep room '''well-lit''' (promotes miosis)
*Position: elevate head of bed, keep room well-lit (promotes miosis)
*'''Start simultaneously with topical beta-blocker, alpha-2 agonist, and systemic carbonic anhydrase inhibitor'''
*Start simultaneously with topical beta-blocker, alpha-2 agonist, and systemic carbonic anhydrase inhibitor


===Decrease Aqueous Humor Production===
===Decrease Aqueous Humor Production===
*'''Timolol 0.5%''': 1 drop in affected eye; repeat in 1 hour if needed
*Timolol 0.5%: 1 drop in affected eye; repeat in 1 hour if needed
**Contraindicated in severe asthma/COPD, bradycardia, heart block
**Contraindicated in severe asthma/COPD, bradycardia, heart block
*'''Acetazolamide 500 mg IV or PO''' (PO preferred unless nauseated)
*Acetazolamide 500 mg IV or PO (PO preferred unless nauseated)
**Contraindicated in '''sickle cell disease''' (promotes sickling in acidic environment)
**Contraindicated in '''sickle cell disease''' (promotes sickling in acidic environment)
**Substitute methazolamide 100 mg if renal failure
**Substitute methazolamide 100 mg if renal failure
*'''Dorzolamide 2%''': topical carbonic anhydrase inhibitor — 1 drop affected eye
*Dorzolamide 2%: topical carbonic anhydrase inhibitor — 1 drop affected eye


===Alpha-2 Agonist===
===Alpha-2 Agonist===
*'''Brimonidine 0.2%''' OR '''apraclonidine 1%''': 1 drop affected eye
*Brimonidine 0.2% OR apraclonidine 1%: 1 drop affected eye
**Reduces aqueous production and increases trabecular outflow
**Reduces aqueous production and increases trabecular outflow


===Facilitate Aqueous Outflow===
===Facilitate Aqueous Outflow===
*'''Pilocarpine 1-2%''': 1 drop affected eye every 15 min x 2-4 doses, then q4-6h
*Pilocarpine 1-2%: 1 drop affected eye every 15 min x 2-4 doses, then q4-6h
**Parasympathomimetic → miosis → pulls iris away from trabecular meshwork
**Parasympathomimetic → miosis → pulls iris away from trabecular meshwork
**'''Likely ineffective until IOP drops below 40-50 mmHg''' (ischemic sphincter muscle) — give immediately anyway
**'''Likely ineffective until IOP drops below 40-50 mmHg''' (ischemic sphincter muscle) — give immediately anyway
Línea 78: Línea 78:


===Reduce Vitreous Volume (Refractory Cases)===
===Reduce Vitreous Volume (Refractory Cases)===
*'''Mannitol 1-2 g/kg IV''' over 45 minutes (most common hyperosmotic agent)
*Mannitol 1-2 g/kg IV over 45 minutes (most common hyperosmotic agent)
**Contraindicated in renal failure; can cause hypotension
**Contraindicated in renal failure; can cause hypotension
*'''50% glycerin or 45% isosorbide 1.5 mL/kg PO''' (rarely used)
*50% glycerin or 45% isosorbide 1.5 mL/kg PO (rarely used)


===Topical Steroids===
===Topical Steroids===
*'''Prednisolone acetate 1%''': 1 drop q15-30min x 4, then q1h
*Prednisolone acetate 1%: 1 drop q15-30min x 4, then q1h
**Not during acute attack; consider '''after IOP controlled''' to reduce inflammation<ref>Guluma K, Lee JE. Ophthalmology. In: ''Rosen's Emergency Medicine''. 9th ed. Elsevier; 2018.</ref>
**Not during acute attack; consider '''after IOP controlled''' to reduce inflammation<ref>Guluma K, Lee JE. Ophthalmology. In: ''Rosen's Emergency Medicine''. 9th ed. Elsevier; 2018.</ref>


==Disposition==
==Disposition==
*'''Admit''' for definitive treatment with '''laser peripheral iridotomy''' (definitive cure)
*Admit for definitive treatment with laser peripheral iridotomy (definitive cure)
*'''Prophylactic iridotomy''' of the fellow (unaffected) eye is standard practice
*Prophylactic iridotomy of the fellow (unaffected) eye is standard practice
*Ophthalmology follow-up within 24 hours
*Ophthalmology follow-up within 24 hours



Revisión actual - 09:35 22 mar 2026

Background

File:Eye angle anatomy.png
Eye angle anatomy.
File:Acute angle closure mechanism.png
Mechanism of acute angle closure.
  • Sudden increase in intraocular pressure (IOP) due to obstruction of aqueous humor outflow through the trabecular meshwork
  • Ophthalmologic emergency — permanent vision loss can occur within hours
  • Normal IOP: 10-21 mmHg; in acute attack: typically 40-80 mmHg
  • Pathophysiology:
    • Pupillary dilation → peripheral iris contacts trabecular meshwork → blocks aqueous outflow
    • Increased posterior chamber pressure → iris bows forward (iris bombe) → further obstruction
  • Risk factors:
    • Hyperopia (farsightedness — smaller anterior chamber)
    • Asian and Inuit descent (anatomically shallow anterior chambers)
    • Female sex, age >40
    • Family history
  • Precipitants: dim lighting, medications causing mydriasis (anticholinergics, sympathomimetics, topiramate), emotional stress

Clinical Features

File:Ciliary flush acute angle closure.jpg
Ciliary/circumcorneal flush and hazy cornea characteristic of acute angle closure glaucoma.
File:Acute angle closure pupil.jpg
Right eye with mid-sized, fixed pupil and ciliary flush.
  • Sudden onset, severe unilateral eye pain
  • Blurred vision with "halos" around lights (corneal edema)
  • Frontal or supraorbital headache
  • Nausea and vomiting (may be prominent → misdiagnosed as GI illness)
  • Fixed, mid-dilated pupil (oval or irregular)
  • Hazy, edematous cornea (steamy appearance)
  • Ciliary flush (conjunctival injection most prominent at limbus)
  • Rock-hard globe on palpation (elevated IOP)
  • Decreased visual acuity

Differential Diagnosis

Unilateral red eye

^Emergent diagnoses
^^Critical diagnoses

Evaluation

  • IOP measurement (Tono-Pen or Goldmann):
    • IOP >21 mmHg (typically >40 mmHg in acute attack)
  • Slit lamp exam:
    • Shallow anterior chamber
    • Corneal edema
    • Cell and flare (inflammatory reaction)
    • Mid-dilated, fixed pupil

Diagnostic Criteria: 3 Signs + 2 Symptoms

  • At least 3 signs: IOP >21 mmHg, conjunctival injection, corneal epithelial edema, mid-dilated nonreactive pupil, shallow anterior chamber
  • At least 2 symptoms: ocular pain, nausea/vomiting, history of intermittent blurring with halos

Management

  • Goal: rapidly lower IOP to prepare for definitive laser iridotomy[1]
  • Emergent ophthalmology consult
  • Recheck IOP at least hourly
  • Position: elevate head of bed, keep room well-lit (promotes miosis)
  • Start simultaneously with topical beta-blocker, alpha-2 agonist, and systemic carbonic anhydrase inhibitor

Decrease Aqueous Humor Production

  • Timolol 0.5%: 1 drop in affected eye; repeat in 1 hour if needed
    • Contraindicated in severe asthma/COPD, bradycardia, heart block
  • Acetazolamide 500 mg IV or PO (PO preferred unless nauseated)
    • Contraindicated in sickle cell disease (promotes sickling in acidic environment)
    • Substitute methazolamide 100 mg if renal failure
  • Dorzolamide 2%: topical carbonic anhydrase inhibitor — 1 drop affected eye

Alpha-2 Agonist

  • Brimonidine 0.2% OR apraclonidine 1%: 1 drop affected eye
    • Reduces aqueous production and increases trabecular outflow

Facilitate Aqueous Outflow

  • Pilocarpine 1-2%: 1 drop affected eye every 15 min x 2-4 doses, then q4-6h
    • Parasympathomimetic → miosis → pulls iris away from trabecular meshwork
    • Likely ineffective until IOP drops below 40-50 mmHg (ischemic sphincter muscle) — give immediately anyway
    • Do NOT use pilocarpine >4% (causes forward iris-lens displacement)
    • Note: miosis makes fundoscopic exam more difficult for ophthalmologist

Reduce Vitreous Volume (Refractory Cases)

  • Mannitol 1-2 g/kg IV over 45 minutes (most common hyperosmotic agent)
    • Contraindicated in renal failure; can cause hypotension
  • 50% glycerin or 45% isosorbide 1.5 mL/kg PO (rarely used)

Topical Steroids

  • Prednisolone acetate 1%: 1 drop q15-30min x 4, then q1h
    • Not during acute attack; consider after IOP controlled to reduce inflammation[2]

Disposition

  • Admit for definitive treatment with laser peripheral iridotomy (definitive cure)
  • Prophylactic iridotomy of the fellow (unaffected) eye is standard practice
  • Ophthalmology follow-up within 24 hours

See Also

References

  1. Primary Angle Closure Preferred Practice Pattern. American Academy of Ophthalmology. 2016.
  2. Guluma K, Lee JE. Ophthalmology. In: Rosen's Emergency Medicine. 9th ed. Elsevier; 2018.
  • Prum BE Jr, et al. Primary angle closure — Preferred Practice Pattern. Ophthalmology. 2016;123(1):P1-P40. PMID 26581557
  • Ah-Kee EY, et al. A review of drug-induced acute angle closure glaucoma. J Ophthalmol. 2015;2015:737053. PMID 25861463
  • Sng CC, Ang M, Barton K. Acute angle closure glaucoma. In: Ophthalmology. 5th ed. Elsevier; 2019.